Article Details

BioNTech SE: Hold Rating Amid Market Challenges and Promising Oncology Prospects

Retrieved on: 2025-05-29 17:18:34

Tags for this article:

Click the tags to see associated articles and topics

BioNTech SE: Hold Rating Amid Market Challenges and Promising Oncology Prospects. View article details on hiswai:

Excerpt

Asad Haider, an analyst from Goldman Sachs, has initiated a new Hold rating on BioNTech SE (BNTX). Asad Haider has given his Hold rating due to a ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo